Skip to content

Preventive effect of ultrasound-guided right phrenic nerve block with ropivacaine on shoulder pain after laparoscopic hysterectomy

Preventive effect of ultrasound-guided right phrenic nerve block with ropivacaine on shoulder pain after laparoscopic hysterectomy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073162
Enrollment
Unknown
Registered
2023-07-03
Start date
2023-07-17
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-laparoscopic shoulder pain

Interventions

Experimental group:Before the establishment of artificial pneumoperitoneum 6ml 0.25% ropivacaine phrenic nerve block
Experimental group:Before the establishment of artificial pneumoperitoneum 6ml 0.3% ropivacaine phrenic nerve block
Experimental group:Before the establishment of artificial pneumoperitoneum 6ml 0.375% ropivacaine phrenic nerve block
Experimental group:After the establishment of artificial pneumoperitoneum 6ml 0.25% ropivacaine phrenic nerve block
Experimental group:After the establishment of artificial pneumoperitoneum 6ml 0.3% ropivacaine phrenic nerve block
Experimental group:After the establishment of artificial pneumoperitoneum 6ml 0.375% ropivacaine phrenic nerve block

Sponsors

The First People's Hospital of Yichang
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) 198 cases of laparoscopic total hysterectomy under general anesthesia; (2) Age: 45 ~ 65 years old; (3) Body weight 50-80kg; (4) ASA grading: ? ~ ?; (5) Preoperative examination of heart, lung, liver and kidney function were normal; (6) Have the ability of independent behavior, clear consciousness and understand the investigation content; (7) Volunteers to participate in the study and sign the agreement.

Exclusion criteria

Exclusion criteria: (1) Hypertension, heart disease, diabetes and other important systemic diseases are poorly controlled or untreated; (2) previous history of neck surgery; (3) shoulder pain related diseases; (4) severe liver, kidney and lung dysfunction; (5) Unable to cooperate with researchers: hearing disorders, neurological and psychiatric diseases, etc.; (6) A history of long-term use of analgesic and sedative drugs and drug use;

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative shoulder pain;visual analogue scale for postoperative shoulder pain;

Secondary

MeasureTime frame
Length of artificial pneumoperitoneum;Propofol dosage;Remifentanil dosage;Postoperative nausea and vomiting;

Countries

China

Contacts

Public ContactLiduan Liu

The First People's Hospital of Yichang

634341738@qq.com+86 136 7727 1389

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026